Marshall Wace »

Maplight Therapeutics shares owned by Marshall Wace

Quarter-by-quarter ownership of Maplight Therapeutics (MPLT) shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in Maplight Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Maplight Therapeutics held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maplight Therapeutics by Marshall Wace

Quarter filed Position value Share count Share price at filing
2025-12-31 $697k 40k 17.57

More positions owned by Marshall Wace

Ishares-s&p 500 Etp (IVV)
Vanguard S&p 500 Etp (VOO)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Eli Lilly & Co Common Stock (LLY)
Alphabet Inc-a Common Stock (GOOGL)
Broadcom Common Stock (AVGO)
Adv Micro Device Equity Option Call Option (AMD)
Meta Platforms-a Common Stock (META)
Walmart Common Stock (WMT)
Tesla Common Stock (TSLA)
Alphabet Inc-c Common Stock (GOOG)
Circle Internet Common Stock (CRCL)

View all positions for Marshall Wace

Top funds holding Maplight Therapeutics

T. Rowe Price Investment Management
Goldman Sachs Group
Vanguard Group
Geode Capital Management
State Street Corporation
Lazard Asset Management
Freestone Grove Partners
Bnp Paribas Investment Partners
Charles Schwab Investment Management
Marshall Wace
TD Asset Management
Bank of New York Mellon
Barclays
Wells Fargo & Company
UBS Group

View all funds holding Maplight Therapeutics